Visually assessed pulmonary emphysema independently predicted modestly elevated all-cause mortality risk over 25 years of follow-up in patients with a history of smoking. After controlling for other ...

Staged LVRS offered similar hospital length of stay and complication rates as bilateral LVRS. Both approaches led to clinically significant improvements in pulmonary function. Notably, the staged ...

Recent research suggests that certain biologic medications called monoclonal antibodies may help treat emphysema more effectively than some current therapies. These medications include benralizumab ...

Emphysema detected on baseline low-dose chest CT (LDCT) in the lung cancer screening cohort of more than 9,000 asymptomatic adults was associated with death from all causes, chronic obstructive ...

VIENNA — Bronchoscopic lung volume reduction (BLVR) was associated with sustained improvements in adults with severe emphysema over a 5-year period, based on data from 190 individuals. The LIBERATE ...

After emerging from stealth earlier this year, Apreo Health has raised $130 million to breathe new life into the development of lung implants for emphysema. The financing comes through a series B ...

Please provide your email address to receive an email when new articles are posted on . A variety of options/tools are needed when treating patients with severe emphysema and breathlessness. A phase 3 ...

Detecting emphysema on a baseline low-dose CT (LDCT) scan for lung cancer screening predicted mortality over 25 years of follow-up in those with a history of smoking, a prospective study showed.